Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive.
Jun 4, 2024
0
0
Research recently published in Drug Resistance Updates has revealed a previously unknown biological process through which breast tumor cells develop resistance to standard treatment, which could open the door for cancer scientists ...
May 29, 2024
0
0
A study which examines the common skin condition, chronic spontaneous urticaria (CSU), characterized by recurrent hives, has been recently published by Trinity College Dublin researchers in the journal Allergy.
May 21, 2024
0
16
Migraine is a neurologic disorder. The severe pain of migraine typically is on one side of the head but may be on both sides. Symptoms also may include nausea, vomiting, sensitivity to light and sound, difficulty speaking, ...
May 8, 2024
0
1
National clinical guidelines for the treatment of COVID-19 vary significantly around the world, with under-resourced countries the most likely to diverge from gold standard (World Health Organization; WHO) treatment recommendations, ...
Apr 22, 2024
1
17
In recent years, the treatment landscape for solid tumors has undergone a notable change. With new cancer treatments, the future looks brighter for many young cancer patients, making fertility issues and future family planning ...
Mar 13, 2024
0
0
In a step forward for breast cancer treatment, researchers at Tohoku University have developed a novel monoclonal antibody that specifically targets a certain type of breast cancer cell. Their findings, published in the International ...
Feb 19, 2024
0
0
Scientists have developed an antibody treatment that shows promise in blocking the potentially deadly effects of fentanyl for nearly a month, raising hopes for a new tool to combat overdoses.
Dec 6, 2023
0
15
The EU said Thursday it had given the green light for US pharmaceutical giant Pfizer's $43-billion acquisition of biotech firm Seagen, specializing in innovative cancer treatment.
Oct 19, 2023
0
0
For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α, is efficacious for achieving ...
Oct 5, 2023
0
1
